Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Baxalta Innovations GmbH
Sponsor

Baxalta Innovations GmbH

Austria Industriestrasse 67, Donaustadt, 1221 Vienna, Austria

About the sponsor

Clinical research in cTTP focuses on ADAMTS13 replacement and the management of microvascular thrombosis linked to severe deficiency of this enzyme. The studies address both prophylactic treatment and on-demand therapy in patients with inherited thrombotic disease.

  • ADAMTS13 replacement therapy
  • Thrombotic microangiopathy
  • Bleeding and clotting balance

The sponsor’s work in this area is centered on haematology and inherited disorders of coagulation control.

About Specializations

Baxalta Innovations GmbH runs clinical trials in conditions such as Primary immunodeficiency syndrome, Thrombotic thrombocytopenic purpura, Von Willebrand's disease, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Primary immunodeficiency syndrome

Not recruiting
InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:Baxalta Innovations GmbH

Thrombotic thrombocytopenic purpura

Not recruiting
InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Apadamtase Alfa
  • Sponsor:Baxalta Innovations GmbH

Von Willebrand's disease

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Octocog Alfa
  • Sponsor:Baxalta Innovations GmbH

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.